Gilead Sciences, Inc. (Nasdaq: GILD) is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need, with primary focus areas including HIV/AIDS, viral hepatitis…
HQ: Foster City, CA, United States of Americawww.gilead.com
USD168.08+0.08%vs prev. close
Performance
1W
+0.71%
1M
+9.47%
3M
+21.48%
1Y
+34.25%
YTD
+36.94%
Valuation
P/E
—
EPS TTM
-3.13
Dividend yield
1.95%
Size and risk
Market cap
$208.5B
Beta
0.37
Price history
GILD price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Gilead Sciences
GILD
Drug Manufacturers - General
Mkt cap (USD bn)
208.5
P/E
—
Div yld
1.95%
1W
+0.7%
1M
+9.5%
3M
+21.5%
6M
+29.7%
1Y
+34.3%
YTD
+36.9%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Gilead Sciences
GILD
Drug Manufacturers - General
208.5
—
1.95%
+0.7%
+9.5%
+21.5%
+29.7%
+34.3%
+36.9%
Subscribe to Equity Analytics to compare GILD with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.